Dong-A Socio Holdings Co Ltd (000640):企業の財務・戦略的SWOT分析

◆英語タイトル:Dong-A Socio Holdings Co Ltd (000640) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH28884FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Dong-A Socio Holdings Co Ltd (000640) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Dong-A Socio Holdings Co Ltd (Dong-A Socio Holdings), formerly Dong-A Pharmaceutical Co., Ltd, a subsidiary of Dong-A Socio Group offers business management services. It operates in various markets such as pharmaceuticals, food and beverages, logistics, IT, and materials. The group focuses on new business investments, development of biomedicines and research and development of new innovative drugs. Its major products include quasi-drug, Bacchus; a cold medicine, Anti-inflammatory, Antipyretic, Analgesic Drug, namely, Panpyrin-T, Panpyrin Q; Morning Care; a tampon; contraceptive medicine such as Myvlar, among others. Dong-A Socio Holdings is headquartered in Seoul, South Korea.

Dong-A Socio Holdings Co Ltd Key Recent Developments

Apr 15,2019: GPHL signs strategic cooperation agreement with Dong-A Pharmaceutical

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Dong-A Socio Holdings Co Ltd – Key Facts
Dong-A Socio Holdings Co Ltd – Key Employees
Dong-A Socio Holdings Co Ltd – Major Products and Services
Dong-A Socio Holdings Co Ltd – History
Dong-A Socio Holdings Co Ltd – Company Statement
Dong-A Socio Holdings Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture
Section 2 – Company Analysis
Company Overview
Dong-A Socio Holdings Co Ltd – Business Description
R&D Overview
Dong-A Socio Holdings Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Dong-A Socio Holdings Co Ltd – Strengths
Dong-A Socio Holdings Co Ltd – Weaknesses
Dong-A Socio Holdings Co Ltd – Opportunities
Dong-A Socio Holdings Co Ltd – Threats
Dong-A Socio Holdings Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Dong-A Socio Holdings Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 15, 2019: GPHL signs strategic cooperation agreement with Dong-A Pharmaceutical
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Dong-A Socio Holdings Co Ltd, Key Facts
Dong-A Socio Holdings Co Ltd, Key Employees
Dong-A Socio Holdings Co Ltd, Major Products and Services
Dong-A Socio Holdings Co Ltd, History
Dong-A Socio Holdings Co Ltd, Subsidiaries
Dong-A Socio Holdings Co Ltd, Affiliate
Dong-A Socio Holdings Co Ltd, Joint Venture
Dong-A Socio Holdings Co Ltd, Key Competitors
Dong-A Socio Holdings Co Ltd, Ratios based on current share price
Dong-A Socio Holdings Co Ltd, Annual Ratios
Dong-A Socio Holdings Co Ltd, Annual Ratios (Cont...1)
Dong-A Socio Holdings Co Ltd, Annual Ratios (Cont...2)
Dong-A Socio Holdings Co Ltd, Interim Ratios
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Dong-A Socio Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Dong-A Socio Holdings Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Dong-A Socio Holdings Co Ltd (000640):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sinochem Group Co Ltd:企業の戦略的SWOT分析
    Sinochem Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Vexim SA – Product Pipeline Analysis, 2018 Uate
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • BiosanaPharma BV:製薬・医療:M&Aディール及び事業提携情報
    Summary BiosanaPharma BV (Biosana) is a biotechnology company engaged in the development of monoclonal antibody biologicals (mAbs), biosimilars and biobetters. Its pipeline products include BP001: biosimilar of Omalizumab (anti-allergy); BP002: biosimilar of Denosumab (anti-osteoporosis); BOX001: or …
  • Alabama Power Co:企業の発電所・SWOT分析2018
    Alabama Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Genera Biosystems Ltd (GBI)-製薬・医療分野:企業M&A・提携分析
    Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pat …
  • Accelerate Diagnostics Inc (AXDX):医療機器:M&Aディール及び事業提携情報
    Summary Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that undertakes the development and commercialization of instrumentation for identification and testing the antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, in …
  • Raley’s Family of Fine Stores:企業の戦略的SWOT分析
    Raley's Family of Fine Stores - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Probiogen AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Probiogen AG (Probiogen) a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeut …
  • Panacea Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The company’s pipeline products include PAN-301-1, a human aspa …
  • Elbit Systems Ltd:戦略・SWOT・企業財務分析
    Elbit Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary Elbit Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Hospital for Sick Children-製薬・医療分野:企業M&A・提携分析
    Summary The Hospital for Sick Children (SickKids) is a healthcare service provider that offers children care services. The hospital offers programs and services including resources, tele-medicine, accommodations, child life, creative arts therapy, child and family-centered care; health records inqui …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • CapitaLand Ltd:戦略・SWOT・企業財務分析
    CapitaLand Ltd - Strategy, SWOT and Corporate Finance Report Summary CapitaLand Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Silence Therapeutics Plc (SLN):企業の財務・戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a developer of therapeutics that channels gene silencing to cure life-threatening diseases. The company's pipeline products include SLN124, SLN500 and SLN360. Its SLN124 is developed for the treatment of cardiovascula …
  • Brunswick Corporation (BC):企業の財務・戦略的SWOT分析
    Brunswick Corporation (BC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Konsortium Transnasional Berhad:戦略・SWOT・企業財務分析
    Konsortium Transnasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Konsortium Transnasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析
    Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Enterprise Ireland:医療機器:M&Aディール及び事業提携情報
    Summary Enterprise Ireland (EI) is an economic development organization that offers enterprise development programs. The organization’s activities include funding supports, export assistance, supports to develop competitiveness, incentives to stimulate in-company research and development, assistance …
  • UCB S.A.:企業の戦略・SWOT・財務分析
    UCB S.A. - Strategy, SWOT and Corporate Finance Report Summary UCB S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Riot Blockchain Inc (RIOT)-医療機器分野:企業M&A・提携分析
    Summary Riot Blockchain Inc (Riot Blockchain), formerly known as Bioptix Inc, is an in-vitro diagnostic company focusing on development of blood-based tests in the diagnosis and treatment of acute appendicitis (AA) in children adolescent and young adult patients. Its product portfolio comprises APPY …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆